A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Everolimus (Primary) ; Letrozole (Primary) ; Metformin (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 20 Jun 2017 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 21 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Jul 2016 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.